# Acadia Realty Trust: overview

AKR · NYSE · CIK 899629 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/akr.md) · [Financials](/companies/akr/financials.md) · [Filings](/companies/akr/filings.md) · [Insiders](/companies/akr/insiders.md)

Latest reported revenue: [$95.4m](/filings/0001193125-26-323776.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Jul 29, 2026 (XBRL us-gaap:Revenues, accession 0001193125-26-323776).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [87.7](/filings/0000950170-24-117714.md) | [93.3 d](/filings/0001193125-26-051677.md) | [104](/filings/0001193125-26-191611.md) | [101](/filings/0001193125-26-323776.md) | not reported | not reported | [103](/filings/0001193125-26-191611.md) | [95.4](/filings/0001193125-26-323776.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [19.9%](/filings/0001193125-25-256341.md) | [17.5% d](/filings/0001193125-26-051677.md) | [14.7%](/filings/0001193125-26-191611.md) | [0.8%](/filings/0001193125-26-323776.md) | not reported | not reported | [153.9%](/filings/0001193125-26-191611.md) | [23.8%](/filings/0001193125-26-323776.md) |
| Net margin | % | [14.0%](/filings/0001193125-25-256341.md) | [15.7% d](/filings/0001193125-26-051677.md) | [(11.2%)](/filings/0001193125-26-191611.md) | [(20.8%)](/filings/0001193125-26-323776.md) | not reported | not reported | [135.1%](/filings/0001193125-26-191611.md) | [23.9%](/filings/0001193125-26-323776.md) |
| Diluted EPS | $ per share | [0.07](/filings/0001193125-25-256341.md) | not reported | [0.01](/filings/0001193125-26-191611.md) | [0.01](/filings/0001193125-26-323776.md) | [0.03](/filings/0001193125-25-256341.md) | not reported | [0.22](/filings/0001193125-26-191611.md) | [0.05](/filings/0001193125-26-323776.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Revenue: us-gaap:Revenues; Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [292](/filings/0000950170-24-016567.md) | [326](/filings/0000950170-24-016567.md) | [339](/filings/0001193125-26-051677.md) | [360](/filings/0001193125-26-051677.md) | [411](/filings/0001193125-26-051677.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [10.5%](/filings/0000950170-24-016567.md) | [20.9%](/filings/0000950170-25-021145.md) | [14.5%](/filings/0001193125-26-051677.md) | [18.3%](/filings/0001193125-26-051677.md) | [12.0%](/filings/0001193125-26-051677.md) |
| Net margin | % | [8.9%](/filings/0000950170-24-016567.md) | [(20.0%)](/filings/0000950170-25-021145.md) | [5.9%](/filings/0001193125-26-051677.md) | [6.0%](/filings/0001193125-26-051677.md) | [4.1%](/filings/0001193125-26-051677.md) |
| Diluted EPS | $ per share | [0.26](/filings/0000950170-24-016567.md) | [(0.40)](/filings/0000950170-25-021145.md) | [0.20](/filings/0001193125-26-051677.md) | [0.19](/filings/0001193125-26-051677.md) | [0.10](/filings/0001193125-26-051677.md) |
| Free cash flow | $m | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Revenue: us-gaap:Revenues; Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/akr/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $508.5m | 24,317,895 |  | Added +1,151,015 |
| [FMR LLC](/funds/315066.md) | 2026-06-30 | $416.2m | 19,902,453 |  | Added +294,647 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $281.8m | 13,475,198 |  | Added +358,519 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $159.4m | 7,550,636 |  | Added +174,882 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $125.4m | 5,998,507 |  | Added +125,838 |
| [MASSACHUSETTS FINANCIAL SERVICES CO /MA/](/funds/912938.md) | 2026-06-30 | $106.8m | 4,825,446 |  | Reduced −390,312 |
| [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $97.8m | 4,678,599 |  | Added +932,442 |
| [PRINCIPAL FINANCIAL GROUP INC](/funds/1126328.md) | 2026-06-30 | $82.7m | 3,954,117 |  | Added +3,317,224 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $78.8m | 3,768,212 |  | Added +268,852 |
| [Nuveen, LLC](/funds/1871926.md) | 2026-06-30 | $65.9m | 3,153,491 |  | Added +136,515 |

## Recent filings

[All 1,067 filings](/companies/akr/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-19 | 16:16 ET | [8-K](/filings/0001193125-26-425260.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-425260 |
| 2026-07-29 | 16:21 ET | [10-Q](/filings/0001193125-26-323776.md) | Quarterly report, period 2026-06-30 | 0001193125-26-323776 |
| 2026-07-28 | 16:21 ET | [8-K](/filings/0001193125-26-321040.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-321040 |
| 2026-06-12 | 18:05 ET | [8-K](/filings/0001104659-26-073037.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-073037 |
| 2026-05-13 | 16:15 ET | [8-K](/filings/0001193125-26-221662.md) | 2.02 Results of operations; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-221662 |
| 2026-04-29 | 16:15 ET | [10-Q](/filings/0001193125-26-191611.md) | Quarterly report, period 2026-03-31 | 0001193125-26-191611 |
| 2026-04-28 | 16:16 ET | [8-K](/filings/0001193125-26-187104.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-187104 |
| 2026-04-20 | 07:59 ET | [8-K](/filings/0001104659-26-045244.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001104659-26-045244 |
| 2026-03-31 | 16:15 ET | [DEF 14A](/filings/0001193125-26-134606.md) | Proxy statement, period 2026-03-31 | 0001193125-26-134606 |
| 2026-02-13 | 16:57 ET | [10-K](/filings/0001193125-26-051677.md) | Annual report, period 2025-12-31 | 0001193125-26-051677 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-051677.md), filed Feb 13, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/3790d73d-10ef-4131-856b-48e520e14952)

## About the filer

- CIK: 899629
- Tickers: AKR
- Exchange: NYSE
- SIC code: 6798 Real Estate Investment Trusts
- State of incorporation: MD
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 11:02 ET. No prices; not investment advice.